Please login to the form below

Not currently logged in
Email:
Password:

EFPIA director general Richard Bergström resigns

Will remain in the role until a successor has been selected

EFPIA Richard BergstromRichard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post.

Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe for the past five years”, Bergström was appointed as director general in 2011, succeeding Brian Ager.

Bergström brought almost 20 years of pharmaceutical industry experience to the role, having started out as a pharmacist before holding a number of senior positions in regulatory affairs for Novartis and Roche.

He had been a member of the EFPIA board for a number of years prior to taking on the top job, joining the association from Swedish research-based pharmaceutical association LIF where he served as its director general.

Commenting on his decision to resign, Bergström said: “I am proud to leave EFPIA at a time when we have developed policies that promote innovation and patient access, such as through the focus on outcomes and on adaptive pathways to speed up the development of new medicines.

“After 15 fantastic years leading industry associations in Sweden and in Brussels, it is time for me to take on a fresh challenge.”

Led by Bergström, the search for his replacement is underway, and he has committed to continuing on as director general until a successor has been identified.

2nd September 2016

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...